IDAHO FALLS, Idaho, Aug. 9, 2017 /PRNewswire/ -- International Isotopes Inc. (OTCQB: INIS) (the "Company") announces that it has obtained several significant contracts for radiological field services that are to be completed during the remainder of 2017. The company reports these contracts are both with the U.S. Department of Energy (DOE) and the International Atomic Energy Agency (IAEA) for work within the U.S. and in South America. All of the contract work will involve performing source removals from inactive radiation therapy devices and shipping these devices to secure locations for storage and disposal.

Steve T. Laflin, President and CEO of the Company, said, "The Company has been continuing to build upon our radiological field service experience and equipment capability for performing these types of activities for several years. The Company has continued to build a reputation for safe, cost-effective, on-time completion of these services, and these recent contract awards are a further recognition of that capability. We have an outstanding group of technicians and engineers that have a real talent for performing these types of activities and the Company's development of a mobile hot cell offers us a real competitive advantage. We anticipate the new contract work is anticipated to be completed in 2017, which should result in approximately a 120% increase in the Radiological Services segment revenue for the year end 2017 compared to the same period in 2016."

About International Isotopes Inc.
International Isotopes Inc. manufactures a full range of nuclear medicine calibration and reference standards and provides radiochemicals for pharmacy compounding, clinical research, and life sciences. The Company also produces bulk cobalt-60 and manufactures a variety of cobalt-60 products such as teletherapy sources, and provides a wide range of radiological field services on a contract basis to clients.

SOURCE International Isotopes Inc.

Rad Oncology Homepage